About Us
Nucelion Therapeutics Private Limited is a wholly owned subsidiary of Bharat Biotech International Limited, a global leader in vaccines and biologics. Nucelion is based in Hyderabad, the leading Biotech hub of India known as the Genome Valley. Though a Bharat Biotech subsidiary, Nucelion operates fully independently – with its own leadership, governance, and systems, to run client programs – including those of Bharat Biotech, but only on third-party, market terms – with confidentiality, data segregation, and IP protection to ensure autonomy, trust, and quality by design.
Dr. Raghu Malapaka
CBO –Nucelion Therapeutics
Raghu Malapaka, Ph.D, CBO, Nucelion. Dr. Raghu Malapaka has an extensive commercial experience in the development and manufacturing of large molecules as well as advanced therapies. He served in leadership roles in global CDMOs including AGC Bio, Thermofisher and WuXi and played key role in bringing some of the earliest CGTs to the patients. He has a PhD in molecular biology and post-doctoral experience at Harvard Medical School.
